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Dr Shunji Sano (Okayama, Japan). Just to clarify, the partial
cavopulmonary connection (PCPC) means the bidirectional Glenn
or hemi-Fontan?
Dr Kasnar-Samprec. We almost always performed a bidirec-
tional Glenn.
Dr Pedo del Nido (Boston, Mass). First, congratulations for
a very timely study. I think all of us are very interested in the tri-
cuspid valve in this particular patient group, and your information
is actually going to be very useful for decision-making. I also
want to thank you for sending me the manuscript with plenty
of time.
I would like to try to delve slightly deeper into some of the in-
formation that you provided and to really try to understand your
recommendation, because I agree with you, but I think the ratio-
nale still needs to be discussed.
The first question I have for you is that if we focus on your group
2, the patients who had improvement in their volume size and tri-
cuspid valve annulus with only the PCPC, if I understand it cor-
rectly, the vast majority of those patients, had some degree of
significant TR, and they improved on their own without any inter-
vention on the tricuspid valve. Is that correct?
Dr Kasnar-Samprec. Yes, 7 of the patients did.
Dr del Nido. If that is the case, can you tell me something about
the surgical factors that might have contributed to that. In other
words, how many of those patients had shunts versus right ventri-
cle to pulmonary artery conduits and what was their Qp/Qs at the
time they underwent the stage 2 procedure?
Dr Kasnar-Samprec. These are the patients operated on be-
tween 2001 and 2010. In the early years, we mostly used aortopul-
monary shunts or modified Blalock-Taussig shunts. Later, wewere
using the right ventricle to pulmonary artery conduits as often as
possible. Studying the 3 groups separately, no significant differ-
ence was seen between the number of Sano shunts and the number
of other shunts used. So, the groups were approximately the same.
We had approximately one quarter of the aortopulmonary shunts
or modified Blalock-Taussig shunts in all groups.
Dr del Nido. But you have no information about the Qp/Qs?
DrKasnar-Samprec.No. Unfortunately, I have no information
on the Qp/Qs.
Dr del Nido. I am sure they all had catheters place, so I think
that information might be available.
Dr Kasnar-Samprec. Yes, definitely.
Dr del Nido. The other question I had, and really it is more of
a concern, and that is that you had a median follow-up of 17
months, which is great, because it is important to know what hap-
pens within that period, but your range was from 7 days to 57
months.
Dr Kasnar-Samprec. Yes.
Dr del Nido. My question is: Clearly your technique evolved
during those 10 years, were there differences in the follow-up pe-
riod for the 3 different groups?
Dr Kasnar-Samprec. No.
Dr del Nido. No differences?1108 The Journal of Thoracic and Cardiovascular SurDr Kasnar-Samprec. No, there were no differences. We had,
all together, 9 patients who underwent follow-up echocardiogra-
phy between 7 and 28 days postoperatively. Actually, only 1 pa-
tient at day 7, the next 4 patients at approximately day 14, and
the rest later.
We sometimes operate on patients who travel from other coun-
tries to our institution, and we did not have all the necessary data
for our study, so we could not reevaluate more recent echocardio-
grams. However, the median time for each group was approxi-
mately 17 months. It was 17 months for group 1, 16 for group 2,
and 18 for group 3. The mean values were also approximately
the same.
Dr del Nido. Okay. Thank you.
My next question relates to your recommendation, which is that
one should consider tricuspid valve repair if the patient has more
than mild tricuspid regurgitation, moderate or severe, at the stage
2 procedure, which gets at the predictive value of your study. You
have 2 groups, 1 group that got better on its own, which was group
2, and 1 group that did not. What would you recommend as a pro-
cedure that would cover both of those groups?
Dr Kasnar-Samprec. When we started the study, we clearly
first looked at whether there is something which we could use to
determine directly before the PCPC, yes, this patient definitely
needs tricuspid surgery; or no, this patient definitely does not.
Our data unfortunately did not show that. So, the 2 graphs I showed
are actually based on the knowledge of what happened after the
PCPC.
It would clearly be very easy to say, yes, in group 3, the annulus
will not change, sowe should do an annuloplasty. In group 2, we do
not have to anything. However, this is unfortunately not the case.
At the time when we are planning the PCPC, we cannot predict
which patient will have an improvement of significant TR or which
will develop significant TR. So, this is definitely a very difficult
question.
Dr del Nido. The flip side of that coin is that if you are suggest-
ing annuloplasty, the annulus size in all your patients was within 2
standard deviations of normal. So, they were all normal. Thus, re-
ducing the annulus might or might not help very much at all. Also,
in fact, the worst group, group 3, had no change in valve annulus,
and it was normal. So, it begs the question.
Dr Kasnar-Samprec. It was normal; however, it was larger
than in the normal population, just as in all of other patients before
PCPC.
Dr del Nido.Usually within plus or minus 2 standard deviations
is considered normal. All your patients, if I understand it correctly,
were within that range.
The other question that I have is that if you consider the Single
Ventricle Reconstruction trial, which was a large trial, they have
a very similar experience. The incidence of more than mild tricus-
pid regurgitation was slightly greater, at stage 2, it was about 18%.
However, if you look 1 year later, or 14 months later, the incidence
was the same, independent of what was done to those children.
The question is: Were those the same children? Also, I think
what your study is showing is that there are different groups.
Some children definitely improve by just having the volume load
removed and then there are those who do not. But we still do not
have a very good predictor of which children will or will not
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DDrKasnar-Samprec.Definitely, we do not have a good predic-
tor. What I did not show here is that we described the morphology
of the TV in all patients who had significant TR. Usually the ante-
rior leaflet was larger, the septal leaflet somewhat smaller, and so
on. So, there are things a surgeon can do, except make the annulus
smaller. There were only 2 cases in which our cardiologist de-
scribed the leaflets as completely normal. All other patients had
something that could have theoretically been addressed at the
PCPC.
Dr J. William Gaynor (Philadelphia, Pa). I enjoyed your pa-
per, too, and I agree this is a very important topic. I also agree
with Pedro that knowing the degree of volume overload estimated
by the Qp/Qs is very important.
Two other questions, and I might have missed this. Were these
echocardiographic measurements taken from reports or were the
echocardiograms read again for this study?
Dr Kasnar-Samprec. They were read again. A single experi-
enced observer looked at every echocardiogram again.
Dr Gaynor. Then second, 1 issue we found that affects the se-
verity of TR in these children is any degree of residual arch ob-
struction. Even fairly mild degrees can cause them to have TR.
Thus, sometimes relief of the arch obstruction can result in an im-
provement in the TR. So, do you have any data about any residual
arch obstruction in any of these children? Had any of them under-
gone balloon dilation or other surgical interventions?
Dr Kasnar-Samprec.Definitely. We perform an angiogram di-
rectly before PCPC. I do not have the data regarding the Qp/Qs
here. However, when our cardiologists find a residual gradient in
the aorta, they perform balloon angioplasty. The patients who un-
derwent angioplasty before PCPC, they are always controlled af-
terward as well. Most of the patients in this study had no
gradient or had a relatively mild gradient. I could say that this
should not be an issue in this study.
Dr Gaynor. But I think it is an important item to check.The Journal of Thoracic and CarDr Kasnar-Samprec. Definitely.
DrGlen Van Arsdell (Toronto, Ontario, Canada). It is an inter-
esting topic and a difficult topic. One of the factors that is becom-
ing clear is that we do not volume unload as much as we think.
Magnetic resonance imaging data have shown, whenmagnetic res-
onance imaging is done later, the patients have a Qp/Qs of about
0.8.
It also is clear that many of them have morphologic problems
that you considered. So, I wondered in the subset of patients
with improvement, did you look to see whether their valve had
a morphologic problem or whether with the temporary volume un-
loading that occurs, it was the patients with annular dilation who
improved? Were you able to differentiate on that basis who might
show improvement?
Dr Kasnar-Samprec. We studied all the patients who had, at
any time, significant TR, we described extra the morphology of
the valves. However, the morphology of the valves was not signif-
icantly different among the groups.
Dr Gerhard Ziemer (Chicago, Ill). I might have missed the in-
formation; however, to judge these outcomes, one should know
something about the intraoperative course, such as surgery per-
formed on bypass, off bypass, and if on bypass, how long were
the bypass times. Because this could have some effect on the myo-
cardial and pulmonary function. You did not present this.
Dr Kasnar-Samprec. Do you mean during the Norwood
operation?
Dr Ziemer. No, during this operation, the Glenn anastomosis,
did you do it on bypass or off bypass?
Dr Kasnar-Samprec. We did all of them on bypass.
Dr Ziemer.Well, if you did all on bypass, it would be interest-
ing to know whether those who did worse by any measure, had
a longer bypass run and just were worse because of that. This is
just information one would like to have, I think.
Dr Kasnar-Samprec. Thank you for the suggestion.diovascular Surgery c Volume 144, Number 5 1109
